Trial intelligence / Profile preview

WGP for Immunity in Prefrail and Frail Elderly

NCT02262091Completed

Sponsor
Nestlé
Start
Aug 2014
Primary completion
Dec 2014
Countries
1
01

Overview

Randomised, double-blind trial (2 arms), sponsored by Nestlé. Primary endpoint: Change from baseline in antibody titers levels. Started Aug 2014; status: completed.

Beyond the preview

Go deeper on NCT02262091.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02262091.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call